… already a staple in our daily life, are frequently becoming tools in the management of our personal health care. With … self-conscious and lead to isolation, which studies have shown exacerbates Parkinson's symptoms and negatively impacts …

… of Parkinson’s research is a therapy that will slow or stop the disease, and this year we made great strides toward … some of those therapies in human testing – approaches targeting the protein alpha-synuclein, a calcium channel … about therapies to slow or stop the Parkinson’s process and how you can get involved in studies. Maggie Kuhl Vice …

… Fast_Facts_for_Fundraisers.pdf …

… agent for treatment of high blood pressure, was shown to be have neuroprotective benefit in models of Parkinson’s disease (PD).  A recently completed Phase II study in a PD population demonstrated …

… J. Fox Foundation Helps Awardees Secure Funds Needed to Develop Novel Parkinson’s Drugs The path to new drugs … the activity of a particular part of the brain that becomes overactive in people with Parkinson’s disease (PD). … of mGluR4-targeted drugs. While it is impossible to predict how quickly the program will advance from this point, Conn …

… and foods, Lynn Kermode couldn’t smell them. She started to grow concerned — what if there was a fire in the house … and not diagnosed with PD) are sent a kit from PPMI to test their smell. After her smell test was scored by the … met did refer her to another clinical study where she may get more answers. “It makes you more knowledgeable. It makes …